nodes	percent_of_prediction	percent_of_DWPC	metapath
Ertapenem—Anorexia—Lisinopril—systemic scleroderma	0.000529	0.000529	CcSEcCtD
Ertapenem—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000528	0.000528	CcSEcCtD
Ertapenem—Pain—Mycophenolic acid—systemic scleroderma	0.000527	0.000527	CcSEcCtD
Ertapenem—Constipation—Mycophenolic acid—systemic scleroderma	0.000527	0.000527	CcSEcCtD
Ertapenem—Weight decreased—Prednisone—systemic scleroderma	0.000524	0.000524	CcSEcCtD
Ertapenem—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000523	0.000523	CcSEcCtD
Ertapenem—Cough—Mycophenolate mofetil—systemic scleroderma	0.00052	0.00052	CcSEcCtD
Ertapenem—Hypotension—Lisinopril—systemic scleroderma	0.000518	0.000518	CcSEcCtD
Ertapenem—Dizziness—Captopril—systemic scleroderma	0.000518	0.000518	CcSEcCtD
Ertapenem—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000516	0.000516	CcSEcCtD
Ertapenem—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000514	0.000514	CcSEcCtD
Ertapenem—Urticaria—Leflunomide—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Ertapenem—Abdominal pain—Leflunomide—systemic scleroderma	0.00051	0.00051	CcSEcCtD
Ertapenem—Body temperature increased—Leflunomide—systemic scleroderma	0.00051	0.00051	CcSEcCtD
Ertapenem—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000507	0.000507	CcSEcCtD
Ertapenem—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000507	0.000507	CcSEcCtD
Ertapenem—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000507	0.000507	CcSEcCtD
Ertapenem—Breast disorder—Methotrexate—systemic scleroderma	0.000506	0.000506	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000505	0.000505	CcSEcCtD
Ertapenem—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000505	0.000505	CcSEcCtD
Ertapenem—Hypersensitivity—Azathioprine—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Ertapenem—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000504	0.000504	CcSEcCtD
Ertapenem—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000503	0.000503	CcSEcCtD
Ertapenem—Insomnia—Lisinopril—systemic scleroderma	0.000502	0.000502	CcSEcCtD
Ertapenem—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000501	0.000501	CcSEcCtD
Ertapenem—Paraesthesia—Lisinopril—systemic scleroderma	0.000498	0.000498	CcSEcCtD
Ertapenem—Vomiting—Captopril—systemic scleroderma	0.000498	0.000498	CcSEcCtD
Ertapenem—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000496	0.000496	CcSEcCtD
Ertapenem—Dyspnoea—Lisinopril—systemic scleroderma	0.000494	0.000494	CcSEcCtD
Ertapenem—Rash—Captopril—systemic scleroderma	0.000494	0.000494	CcSEcCtD
Ertapenem—Dermatitis—Captopril—systemic scleroderma	0.000493	0.000493	CcSEcCtD
Ertapenem—Somnolence—Lisinopril—systemic scleroderma	0.000493	0.000493	CcSEcCtD
Ertapenem—Headache—Captopril—systemic scleroderma	0.000491	0.000491	CcSEcCtD
Ertapenem—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00049	0.00049	CcSEcCtD
Ertapenem—Dyspepsia—Lisinopril—systemic scleroderma	0.000488	0.000488	CcSEcCtD
Ertapenem—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000487	0.000487	CcSEcCtD
Ertapenem—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000487	0.000487	CcSEcCtD
Ertapenem—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000486	0.000486	CcSEcCtD
Ertapenem—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000486	0.000486	CcSEcCtD
Ertapenem—Asthma—Methotrexate—systemic scleroderma	0.000484	0.000484	CcSEcCtD
Ertapenem—Infection—Mycophenolate mofetil—systemic scleroderma	0.000483	0.000483	CcSEcCtD
Ertapenem—Decreased appetite—Lisinopril—systemic scleroderma	0.000482	0.000482	CcSEcCtD
Ertapenem—Eosinophilia—Methotrexate—systemic scleroderma	0.000479	0.000479	CcSEcCtD
Ertapenem—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000479	0.000479	CcSEcCtD
Ertapenem—Fatigue—Lisinopril—systemic scleroderma	0.000478	0.000478	CcSEcCtD
Ertapenem—Shock—Mycophenolate mofetil—systemic scleroderma	0.000478	0.000478	CcSEcCtD
Ertapenem—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000477	0.000477	CcSEcCtD
Ertapenem—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000476	0.000476	CcSEcCtD
Ertapenem—Hypersensitivity—Leflunomide—systemic scleroderma	0.000476	0.000476	CcSEcCtD
Ertapenem—Pancreatitis—Methotrexate—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Ertapenem—Pain—Lisinopril—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Ertapenem—Constipation—Lisinopril—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Ertapenem—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Ertapenem—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000472	0.000472	CcSEcCtD
Ertapenem—Bradycardia—Prednisone—systemic scleroderma	0.000472	0.000472	CcSEcCtD
Ertapenem—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00047	0.00047	CcSEcCtD
Ertapenem—Diarrhoea—Azathioprine—systemic scleroderma	0.000468	0.000468	CcSEcCtD
Ertapenem—Haemoglobin—Prednisone—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Ertapenem—Nausea—Captopril—systemic scleroderma	0.000465	0.000465	CcSEcCtD
Ertapenem—Haemorrhage—Prednisone—systemic scleroderma	0.000464	0.000464	CcSEcCtD
Ertapenem—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000463	0.000463	CcSEcCtD
Ertapenem—Asthenia—Leflunomide—systemic scleroderma	0.000463	0.000463	CcSEcCtD
Ertapenem—Hallucination—Prednisone—systemic scleroderma	0.000461	0.000461	CcSEcCtD
Ertapenem—Feeling abnormal—Lisinopril—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Ertapenem—Pruritus—Leflunomide—systemic scleroderma	0.000457	0.000457	CcSEcCtD
Ertapenem—Connective tissue disorder—Prednisone—systemic scleroderma	0.000456	0.000456	CcSEcCtD
Ertapenem—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000454	0.000454	CcSEcCtD
Ertapenem—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000454	0.000454	CcSEcCtD
Ertapenem—Dysuria—Methotrexate—systemic scleroderma	0.000453	0.000453	CcSEcCtD
Ertapenem—Neutropenia—Methotrexate—systemic scleroderma	0.000453	0.000453	CcSEcCtD
Ertapenem—Dizziness—Azathioprine—systemic scleroderma	0.000452	0.000452	CcSEcCtD
Ertapenem—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.00045	0.00045	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Ertapenem—Asthenia—Mycophenolic acid—systemic scleroderma	0.000442	0.000442	CcSEcCtD
Ertapenem—Diarrhoea—Leflunomide—systemic scleroderma	0.000442	0.000442	CcSEcCtD
Ertapenem—Urticaria—Lisinopril—systemic scleroderma	0.000441	0.000441	CcSEcCtD
Ertapenem—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00044	0.00044	CcSEcCtD
Ertapenem—Abdominal pain—Lisinopril—systemic scleroderma	0.000438	0.000438	CcSEcCtD
Ertapenem—Body temperature increased—Lisinopril—systemic scleroderma	0.000438	0.000438	CcSEcCtD
Ertapenem—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000436	0.000436	CcSEcCtD
Ertapenem—Pruritus—Mycophenolic acid—systemic scleroderma	0.000436	0.000436	CcSEcCtD
Ertapenem—Vomiting—Azathioprine—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Ertapenem—Pneumonia—Methotrexate—systemic scleroderma	0.000434	0.000434	CcSEcCtD
Ertapenem—Eye disorder—Prednisone—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Ertapenem—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Ertapenem—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000432	0.000432	CcSEcCtD
Ertapenem—Infestation NOS—Methotrexate—systemic scleroderma	0.000432	0.000432	CcSEcCtD
Ertapenem—Infestation—Methotrexate—systemic scleroderma	0.000432	0.000432	CcSEcCtD
Ertapenem—Rash—Azathioprine—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Ertapenem—Dermatitis—Azathioprine—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Ertapenem—Flushing—Prednisone—systemic scleroderma	0.00043	0.00043	CcSEcCtD
Ertapenem—Headache—Azathioprine—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Ertapenem—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Ertapenem—Dizziness—Leflunomide—systemic scleroderma	0.000427	0.000427	CcSEcCtD
Ertapenem—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000422	0.000422	CcSEcCtD
Ertapenem—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Ertapenem—Stomatitis—Methotrexate—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Ertapenem—Angiopathy—Prednisone—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Ertapenem—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00042	0.00042	CcSEcCtD
Ertapenem—Immune system disorder—Prednisone—systemic scleroderma	0.000419	0.000419	CcSEcCtD
Ertapenem—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Ertapenem—Pain—Mycophenolate mofetil—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Ertapenem—Arrhythmia—Prednisone—systemic scleroderma	0.000414	0.000414	CcSEcCtD
Ertapenem—Sweating—Methotrexate—systemic scleroderma	0.000414	0.000414	CcSEcCtD
Ertapenem—Haematuria—Methotrexate—systemic scleroderma	0.000412	0.000412	CcSEcCtD
Ertapenem—Vomiting—Leflunomide—systemic scleroderma	0.00041	0.00041	CcSEcCtD
Ertapenem—Hypersensitivity—Lisinopril—systemic scleroderma	0.000409	0.000409	CcSEcCtD
Ertapenem—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000408	0.000408	CcSEcCtD
Ertapenem—Dizziness—Mycophenolic acid—systemic scleroderma	0.000407	0.000407	CcSEcCtD
Ertapenem—Epistaxis—Methotrexate—systemic scleroderma	0.000407	0.000407	CcSEcCtD
Ertapenem—Rash—Leflunomide—systemic scleroderma	0.000407	0.000407	CcSEcCtD
Ertapenem—Dermatitis—Leflunomide—systemic scleroderma	0.000407	0.000407	CcSEcCtD
Ertapenem—Mental disorder—Prednisone—systemic scleroderma	0.000406	0.000406	CcSEcCtD
Ertapenem—Nausea—Azathioprine—systemic scleroderma	0.000406	0.000406	CcSEcCtD
Ertapenem—Headache—Leflunomide—systemic scleroderma	0.000404	0.000404	CcSEcCtD
Ertapenem—Erythema—Prednisone—systemic scleroderma	0.000404	0.000404	CcSEcCtD
Ertapenem—Malnutrition—Prednisone—systemic scleroderma	0.000404	0.000404	CcSEcCtD
Ertapenem—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.0004	0.0004	CcSEcCtD
Ertapenem—Asthenia—Lisinopril—systemic scleroderma	0.000398	0.000398	CcSEcCtD
Ertapenem—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000397	0.000397	CcSEcCtD
Ertapenem—Pruritus—Lisinopril—systemic scleroderma	0.000392	0.000392	CcSEcCtD
Ertapenem—Vomiting—Mycophenolic acid—systemic scleroderma	0.000391	0.000391	CcSEcCtD
Ertapenem—Haemoglobin—Methotrexate—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Ertapenem—Rash—Mycophenolic acid—systemic scleroderma	0.000388	0.000388	CcSEcCtD
Ertapenem—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000388	0.000388	CcSEcCtD
Ertapenem—Haemorrhage—Methotrexate—systemic scleroderma	0.000387	0.000387	CcSEcCtD
Ertapenem—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000386	0.000386	CcSEcCtD
Ertapenem—Headache—Mycophenolic acid—systemic scleroderma	0.000386	0.000386	CcSEcCtD
Ertapenem—Pharyngitis—Methotrexate—systemic scleroderma	0.000385	0.000385	CcSEcCtD
Ertapenem—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000384	0.000384	CcSEcCtD
Ertapenem—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000384	0.000384	CcSEcCtD
Ertapenem—Nausea—Leflunomide—systemic scleroderma	0.000383	0.000383	CcSEcCtD
Ertapenem—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000383	0.000383	CcSEcCtD
Ertapenem—Urethral disorder—Methotrexate—systemic scleroderma	0.00038	0.00038	CcSEcCtD
Ertapenem—Diarrhoea—Lisinopril—systemic scleroderma	0.000379	0.000379	CcSEcCtD
Ertapenem—Ill-defined disorder—Prednisone—systemic scleroderma	0.000374	0.000374	CcSEcCtD
Ertapenem—Anaemia—Prednisone—systemic scleroderma	0.000373	0.000373	CcSEcCtD
Ertapenem—Agitation—Prednisone—systemic scleroderma	0.000371	0.000371	CcSEcCtD
Ertapenem—Dizziness—Lisinopril—systemic scleroderma	0.000367	0.000367	CcSEcCtD
Ertapenem—Nausea—Mycophenolic acid—systemic scleroderma	0.000366	0.000366	CcSEcCtD
Ertapenem—Malaise—Prednisone—systemic scleroderma	0.000364	0.000364	CcSEcCtD
Ertapenem—Vertigo—Prednisone—systemic scleroderma	0.000363	0.000363	CcSEcCtD
Ertapenem—Eye disorder—Methotrexate—systemic scleroderma	0.000362	0.000362	CcSEcCtD
Ertapenem—Syncope—Prednisone—systemic scleroderma	0.000362	0.000362	CcSEcCtD
Ertapenem—Cardiac disorder—Methotrexate—systemic scleroderma	0.00036	0.00036	CcSEcCtD
Ertapenem—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000358	0.000358	CcSEcCtD
Ertapenem—Loss of consciousness—Prednisone—systemic scleroderma	0.000355	0.000355	CcSEcCtD
Ertapenem—Vomiting—Lisinopril—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Ertapenem—Angiopathy—Methotrexate—systemic scleroderma	0.000352	0.000352	CcSEcCtD
Ertapenem—Immune system disorder—Methotrexate—systemic scleroderma	0.00035	0.00035	CcSEcCtD
Ertapenem—Rash—Lisinopril—systemic scleroderma	0.00035	0.00035	CcSEcCtD
Ertapenem—Convulsion—Prednisone—systemic scleroderma	0.00035	0.00035	CcSEcCtD
Ertapenem—Dermatitis—Lisinopril—systemic scleroderma	0.000349	0.000349	CcSEcCtD
Ertapenem—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000349	0.000349	CcSEcCtD
Ertapenem—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000349	0.000349	CcSEcCtD
Ertapenem—Hypertension—Prednisone—systemic scleroderma	0.000348	0.000348	CcSEcCtD
Ertapenem—Chills—Methotrexate—systemic scleroderma	0.000348	0.000348	CcSEcCtD
Ertapenem—Headache—Lisinopril—systemic scleroderma	0.000347	0.000347	CcSEcCtD
Ertapenem—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000344	0.000344	CcSEcCtD
Ertapenem—Arthralgia—Prednisone—systemic scleroderma	0.000344	0.000344	CcSEcCtD
Ertapenem—Anxiety—Prednisone—systemic scleroderma	0.000342	0.000342	CcSEcCtD
Ertapenem—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000341	0.000341	CcSEcCtD
Ertapenem—Discomfort—Prednisone—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Ertapenem—Mental disorder—Methotrexate—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Ertapenem—Erythema—Methotrexate—systemic scleroderma	0.000337	0.000337	CcSEcCtD
Ertapenem—Malnutrition—Methotrexate—systemic scleroderma	0.000337	0.000337	CcSEcCtD
Ertapenem—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000332	0.000332	CcSEcCtD
Ertapenem—Dysgeusia—Methotrexate—systemic scleroderma	0.00033	0.00033	CcSEcCtD
Ertapenem—Nausea—Lisinopril—systemic scleroderma	0.000329	0.000329	CcSEcCtD
Ertapenem—Anaphylactic shock—Prednisone—systemic scleroderma	0.000329	0.000329	CcSEcCtD
Ertapenem—Oedema—Prednisone—systemic scleroderma	0.000329	0.000329	CcSEcCtD
Ertapenem—Infection—Prednisone—systemic scleroderma	0.000327	0.000327	CcSEcCtD
Ertapenem—Shock—Prednisone—systemic scleroderma	0.000324	0.000324	CcSEcCtD
Ertapenem—Nervous system disorder—Prednisone—systemic scleroderma	0.000323	0.000323	CcSEcCtD
Ertapenem—Tachycardia—Prednisone—systemic scleroderma	0.000321	0.000321	CcSEcCtD
Ertapenem—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000321	0.000321	CcSEcCtD
Ertapenem—Skin disorder—Prednisone—systemic scleroderma	0.00032	0.00032	CcSEcCtD
Ertapenem—Hyperhidrosis—Prednisone—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Ertapenem—Anorexia—Prednisone—systemic scleroderma	0.000314	0.000314	CcSEcCtD
Ertapenem—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000313	0.000313	CcSEcCtD
Ertapenem—Anaemia—Methotrexate—systemic scleroderma	0.000312	0.000312	CcSEcCtD
Ertapenem—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Ertapenem—Rash—Mycophenolate mofetil—systemic scleroderma	0.000306	0.000306	CcSEcCtD
Ertapenem—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000306	0.000306	CcSEcCtD
Ertapenem—Headache—Mycophenolate mofetil—systemic scleroderma	0.000304	0.000304	CcSEcCtD
Ertapenem—Malaise—Methotrexate—systemic scleroderma	0.000304	0.000304	CcSEcCtD
Ertapenem—Vertigo—Methotrexate—systemic scleroderma	0.000303	0.000303	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.0003	0.0003	CcSEcCtD
Ertapenem—Insomnia—Prednisone—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Ertapenem—Paraesthesia—Prednisone—systemic scleroderma	0.000296	0.000296	CcSEcCtD
Ertapenem—Cough—Methotrexate—systemic scleroderma	0.000294	0.000294	CcSEcCtD
Ertapenem—Convulsion—Methotrexate—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Ertapenem—Dyspepsia—Prednisone—systemic scleroderma	0.00029	0.00029	CcSEcCtD
Ertapenem—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000289	0.000289	CcSEcCtD
Ertapenem—Chest pain—Methotrexate—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Ertapenem—Arthralgia—Methotrexate—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Ertapenem—Decreased appetite—Prednisone—systemic scleroderma	0.000286	0.000286	CcSEcCtD
Ertapenem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000285	0.000285	CcSEcCtD
Ertapenem—Fatigue—Prednisone—systemic scleroderma	0.000284	0.000284	CcSEcCtD
Ertapenem—Discomfort—Methotrexate—systemic scleroderma	0.000284	0.000284	CcSEcCtD
Ertapenem—Constipation—Prednisone—systemic scleroderma	0.000282	0.000282	CcSEcCtD
Ertapenem—Confusional state—Methotrexate—systemic scleroderma	0.000278	0.000278	CcSEcCtD
Ertapenem—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000275	0.000275	CcSEcCtD
Ertapenem—Infection—Methotrexate—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Ertapenem—Feeling abnormal—Prednisone—systemic scleroderma	0.000271	0.000271	CcSEcCtD
Ertapenem—Nervous system disorder—Methotrexate—systemic scleroderma	0.00027	0.00027	CcSEcCtD
Ertapenem—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00027	0.00027	CcSEcCtD
Ertapenem—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000269	0.000269	CcSEcCtD
Ertapenem—Skin disorder—Methotrexate—systemic scleroderma	0.000267	0.000267	CcSEcCtD
Ertapenem—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000266	0.000266	CcSEcCtD
Ertapenem—Anorexia—Methotrexate—systemic scleroderma	0.000262	0.000262	CcSEcCtD
Ertapenem—Urticaria—Prednisone—systemic scleroderma	0.000262	0.000262	CcSEcCtD
Ertapenem—Body temperature increased—Prednisone—systemic scleroderma	0.00026	0.00026	CcSEcCtD
Ertapenem—Abdominal pain—Prednisone—systemic scleroderma	0.00026	0.00026	CcSEcCtD
Ertapenem—Hypotension—Methotrexate—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000251	0.000251	CcSEcCtD
Ertapenem—Insomnia—Methotrexate—systemic scleroderma	0.000249	0.000249	CcSEcCtD
Ertapenem—Paraesthesia—Methotrexate—systemic scleroderma	0.000247	0.000247	CcSEcCtD
Ertapenem—Dyspnoea—Methotrexate—systemic scleroderma	0.000245	0.000245	CcSEcCtD
Ertapenem—Somnolence—Methotrexate—systemic scleroderma	0.000245	0.000245	CcSEcCtD
Ertapenem—Hypersensitivity—Prednisone—systemic scleroderma	0.000243	0.000243	CcSEcCtD
Ertapenem—Dyspepsia—Methotrexate—systemic scleroderma	0.000242	0.000242	CcSEcCtD
Ertapenem—Decreased appetite—Methotrexate—systemic scleroderma	0.000239	0.000239	CcSEcCtD
Ertapenem—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000238	0.000238	CcSEcCtD
Ertapenem—Fatigue—Methotrexate—systemic scleroderma	0.000237	0.000237	CcSEcCtD
Ertapenem—Asthenia—Prednisone—systemic scleroderma	0.000236	0.000236	CcSEcCtD
Ertapenem—Pain—Methotrexate—systemic scleroderma	0.000235	0.000235	CcSEcCtD
Ertapenem—Pruritus—Prednisone—systemic scleroderma	0.000233	0.000233	CcSEcCtD
Ertapenem—Feeling abnormal—Methotrexate—systemic scleroderma	0.000227	0.000227	CcSEcCtD
Ertapenem—Diarrhoea—Prednisone—systemic scleroderma	0.000225	0.000225	CcSEcCtD
Ertapenem—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000225	0.000225	CcSEcCtD
Ertapenem—Urticaria—Methotrexate—systemic scleroderma	0.000219	0.000219	CcSEcCtD
Ertapenem—Dizziness—Prednisone—systemic scleroderma	0.000218	0.000218	CcSEcCtD
Ertapenem—Abdominal pain—Methotrexate—systemic scleroderma	0.000218	0.000218	CcSEcCtD
Ertapenem—Body temperature increased—Methotrexate—systemic scleroderma	0.000218	0.000218	CcSEcCtD
Ertapenem—Vomiting—Prednisone—systemic scleroderma	0.000209	0.000209	CcSEcCtD
Ertapenem—Rash—Prednisone—systemic scleroderma	0.000208	0.000208	CcSEcCtD
Ertapenem—Dermatitis—Prednisone—systemic scleroderma	0.000207	0.000207	CcSEcCtD
Ertapenem—Headache—Prednisone—systemic scleroderma	0.000206	0.000206	CcSEcCtD
Ertapenem—Hypersensitivity—Methotrexate—systemic scleroderma	0.000203	0.000203	CcSEcCtD
Ertapenem—Asthenia—Methotrexate—systemic scleroderma	0.000198	0.000198	CcSEcCtD
Ertapenem—Nausea—Prednisone—systemic scleroderma	0.000196	0.000196	CcSEcCtD
Ertapenem—Pruritus—Methotrexate—systemic scleroderma	0.000195	0.000195	CcSEcCtD
Ertapenem—Diarrhoea—Methotrexate—systemic scleroderma	0.000188	0.000188	CcSEcCtD
Ertapenem—Dizziness—Methotrexate—systemic scleroderma	0.000182	0.000182	CcSEcCtD
Ertapenem—Vomiting—Methotrexate—systemic scleroderma	0.000175	0.000175	CcSEcCtD
Ertapenem—Rash—Methotrexate—systemic scleroderma	0.000174	0.000174	CcSEcCtD
Ertapenem—Dermatitis—Methotrexate—systemic scleroderma	0.000173	0.000173	CcSEcCtD
Ertapenem—Headache—Methotrexate—systemic scleroderma	0.000172	0.000172	CcSEcCtD
Ertapenem—Nausea—Methotrexate—systemic scleroderma	0.000164	0.000164	CcSEcCtD
